Biocubik
De berekende faillissementskans van Biocubik over 12 maanden bedraagt 1,0% (laag). De jaarrekening over 2025 toont een eigen vermogen van €500k en een nettoresultaat van €-48k. De cijfers schommelen te sterk van jaar tot jaar voor een betrouwbare trendprojectie. De solvabiliteit is beter dan 84% van 81 sectorgenoten (boekjaar 2025). Het bedrijf is actief sinds 2022 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen.
| Eigen vermogen | €500k |
| Netto resultaat | €-48k |
| Werknemers (VTE) | 1,9 |
| Beter dan sector | 84% |
Sterk profiel, met solvabiliteit als uitschieter.
Alle 5 assen zijn berekend uit gegevens die Checked heeft ingelezen.
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je vanaf Kantoor S.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | 84,4% | 49,8% | |
| Nettoresultaat | €-48k | €17k | |
| Eigen vermogen | €500k | €102k | |
| Bruto bedrijfsmarge | €68k | €49k | |
| Totaal activa | €593k | €250k |
| Boekjaar | 2025 |
|---|---|
| Neerlegging | volledig |
| Omzet | - |
| EBITDA | €-41k |
| Nettoresultaat | €-48k |
| Cashflow | €-42k |
| Personeelskosten | €108k |
| Belastingen op het resultaat | €277 |
| Dividenden | - |
| Totaal activa | €593k |
| Eigen vermogen | €500k |
| Schulden | €93k |
| waarvan ≤ 1 jaar | €80k |
| waarvan > 1 jaar | €13k |
| Werkkapitaal | €427k |
| Werknemers (VTE) | 1,9 |
| 2025 | |
|---|---|
| Current ratio | 6,32 |
| Quick ratio | 5,01 |
| Werkkapitaalratio | 72,1% |
| Solvabiliteit | 84,4% |
| Debt / equity | 0,19 |
| Langetermijnschuldgraad | 0,02 |
| Interest coverage | -16,72 |
| Bruto rentabiliteit | - |
| Netto rentabiliteit | - |
| ROA | -8,1% |
| ROE | -9,6% |
| EBITDA-marge | - |
| Klantenkrediet (DSO) | - |
| Leverancierskrediet (DPO) | - |
| Voorraadrotatie | - |
| Voorraaddagen (DSI) | - |
| Post | Code | 2025 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €593k |
| Vaste activa | 21/28 | €85k |
| Immateriële vaste activa | 21 | €83k |
| Materiële vaste activa | 22/27 | €2k |
| Vlottende activa | 29/58 | €507k |
| Voorraden en bestellingen in uitvoering | 3 | €105k |
| Vorderingen op ten hoogste één jaar | 40/41 | €218k |
| Liquide middelen | 54/58 | €183k |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €593k |
| Eigen vermogen | 10/15 | €500k |
| Inbreng / kapitaal | 10/11 | €550k |
| Overgedragen winst (verlies) | 14 | €-329k |
| Schulden | 17/49 | €93k |
| Schulden op meer dan één jaar | 17 | €13k |
| Schulden op ten hoogste één jaar | 42/48 | €80k |
| Handelsschulden op ten hoogste één jaar | 44 | €38k |
| Resultatenrekening | ||
| Bruto bedrijfsmarge | 9900 | €68k |
| Bedrijfsresultaat | 9901 | €-47k |
| Financiële opbrengsten | 75 | €2k |
| Financiële kosten | 65 | €2k |
| Resultaat vóór belasting | 9903 | €-48k |
| Belastingen op het resultaat | 67/77 | €277 |
| Resultaat van het boekjaar | 9904 | €-48k |
| Te bestemmen resultaat | 9905 | €-48k |
| NACE primair | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 07-03-2022 |
| Status | Actief |
| Postcode | 4102 |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
14-05-2025 Kapitaalverhoging van €250.000 tot €550.000
- €300.000 → €550.000
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 550000.0,
"delta_eur": 250000.0,
"before_eur": 300000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "KAZOKU",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 2500,
"contribution_amount_eur": 250000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 2500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 250000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Fran\u00E7ois Catinus",
"firm_city": null,
"firm_name": null,
"office_city": "Bastogne",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-05-14",
"filing_date": "2025-04-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2025-04-24",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-04-23"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0782.955.294",
"name_full": "BIOCUBIK TRIBU",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"_kbo_filled_from_list": true,
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}25-04-2025 Kapitaalverhoging van €250.000 tot €550.000
- €300.000 → €550.000
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 100.0
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 550000.0,
"delta_eur": 250000.0,
"before_eur": 300000.0,
"subscribers": [
{
"kbo": "0787.215.475",
"rrn": null,
"kind": "org",
"name": "KAZOKU",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 250,
"contribution_amount_eur": 250000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 5500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 100.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 250000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Fran\u00E7ois Catinus",
"firm_city": null,
"firm_name": null,
"office_city": "Bastogne",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-04-25",
"filing_date": "2025-04-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale",
"act_date": "2025-04-23",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0782.955.294",
"name_full": "BIOCUBIK",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": "0787.215.475",
"pct": null,
"kind": "org",
"name": "KAZOKU",
"role": null,
"n_shares": 250,
"share_class": null
}
],
"share_classes_after": []
}08-12-2023 Herstructurering van de aandelenklassen
Technische details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0787.215.475",
"rrn": null,
"kind": "org",
"name": "KAZOKU",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 2800,
"contribution_amount_eur": 280000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "DELADRIERE Jean-Luc",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 100,
"contribution_amount_eur": 10000.0
},
{
"kbo": "0787.215.475",
"rrn": null,
"kind": "org",
"name": "KAZOKU",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 1000,
"contribution_amount_eur": 100000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2900,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 100.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 3000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Fran\u00E7ois Catinus",
"firm_city": null,
"firm_name": null,
"office_city": "Florenville",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-12-08",
"filing_date": "2023-12-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-12-06",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2023-12-06"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0782.955.294",
"name_full": "BIOCUBIK",
"legal_form": "SRL",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition"
],
"shareholders_after": [
{
"kbo": "0787.215.475",
"pct": null,
"kind": "org",
"name": "KAZOKU",
"role": null,
"n_shares": 3800,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "DELADRIERE Jean-Luc",
"role": null,
"n_shares": 100,
"share_class": null
}
],
"share_classes_after": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | Biocubik |
| AfkortingFR | bcbk |
| HandelsnaamFR | Biocubik |